Form 4 for DMAC DiaMedica Therapeutics Inc.
Accepted 2022-12-06 00:00:00 ET · period of report 2022-12-02 · accession 0001567619-22-021344 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-12-06 | 2022-12-02 | DMAC | Von Koch Thomas | 10% | P - Purchase | $1.24 | +2.86M | 2.86M | New | +$3.54M |
| I | 2022-12-06 | 2022-12-02 | DMAC | Von Koch Thomas | 10% | S - Sale | $1.24 | -2.86M | 0 | -100% | -$3.54M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-12-02 | P | A | 2,855,847 | $1.24 | 2,855,847 | I See Footnote 2 | — | — | (F2) These shares are owned directly by TomEqt Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEqt Private AB. Thomas Von Koch has the sole power to vote and dispose of these shares. |
| 2 | Common | Common Shares | 2022-12-02 | S | D | 2,855,847 | $1.24 | 0 | I See Footnote 1 | — | — | (F1) These shares were owned directly by TomEnterprise AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares. |